BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 20, 2001
View Archived Issues
Cyclic D,L-alpha peptides exert antibacterial activity against MRSA
Read More
Cataracts improve with N-acetylcarnosine drops
Read More
Lifestyle modification or Glucophage markedly reduce progression to type 2 diabetes
Read More
LAR formulations of Amylin's synthetic exendin-4 offer potential for monthly dosing
Read More
BioCryst's oral influenza neuraminidase inhibitor to enter phase III trial in U.S.
Read More
Onyx regains development rights for nonintravenous administration of ONYX-015
Read More
Encouraging phase I results reported for Supratek's lead oncology product
Read More
Geron and Kyowa Hakko select telomerase inhibitor for development
Read More
Five statins available in the U.S. as alternatives to Baycol
Read More
Schering-Plough and Roche resolve peginterferon patent disputes
Read More
Phase I trial initiated for Inspire's sinusitis therapy
Read More
Phase I study successful for Prescient NeuroPharma's anhydrovinblastine
Read More
Flavonoid consumption associated with reduced incidence of COPD
Read More
SI-6601D found useful for local therapy in rheumatoid arthritis patients
Read More
Roche designs new compounds for the treatment of type 2 diabetes
Read More
Compounds for the treatment of cellular protein transport disorders reported by Procter & Gamble
Read More
Icos patents new potent and selective PDE4 inhibitors
Read More
Merck & Co. describes novel derivatives as selective ligands for GABA-A receptors
Read More
C&C Research presents several new series of compounds with antiestrogenic activity
Read More
